EE124 Cost-Effectiveness Analysis of Dolutegravir/Lamivudine (DTG/3TC) Versus Elvitegravir/Cobicistat/Tenofovir Alafenamide/Emtricitabine (EVG/C/TAF/FTC) for HIV-1 Infection Management in Treatment-Experienced Patients in China
Abstract
Authors
L. Fan Z. Tang I. Jacob S.J. Anderson M. Kabra M. Turner A. Tewary C. Harrison